Small molecule inhibitors of ALDH and uses thereof Grant US-11944626-B2 United States of America 02 Apr 2024
Methods and compositions involving miR-135b for distinguishing pancreatic cancer from… Grant US-10655184-B2 United States of America 19 May 2020
Anti-DLL3 antibody drug conjugates for treating cancer Grant US-10478509-B2 United States of America 19 Nov 2019
Anti-DLL3 antibodies and drug conjugates for use in melanoma Grant US-10308721-B2 United States of America 04 Jun 2019
Anti-DLL3 antibody drug conjugates for treating cancer Grant US-10137204-B2 United States of America 27 Nov 2018
Methods and compositions involving MicroRNA Grant US-10047388-B2 United States of America 14 Aug 2018
Site-specific antibody conjugation methods and compositions Grant US-10035853-B2 United States of America 31 Jul 2018
Identification and enrichment of cell subpopulations Grant US-9945842-B2 United States of America 17 Apr 2018
Anti-DLL3 antibody drug conjugates and methods of use Grant US-9937268-B2 United States of America 10 Apr 2018
Methods of delivering DLL3 antibody drug conjugates Grant US-9931421-B2 United States of America 03 Apr 2018
Methods of making DLL3 antibody drug conjugates Grant US-9931420-B2 United States of America 03 Apr 2018
Methods of delivering DLL3 antibody drug conjugates Grant US-9878053-B2 United States of America 30 Jan 2018
Kits containing DLL3 antibody drug conjugates Grant US-9861708-B2 United States of America 09 Jan 2018
Anti-DLL3 antibody drug conjugates for treating cancer Grant US-9775916-B1 United States of America 03 Oct 2017
Methods of making DLL3 antibody drug conjugates Grant US-9764042-B1 United States of America 19 Sep 2017
Methods and compositions involving miR-135B for distinguishing pancreatic cancer from… Grant US-9644241-B2 United States of America 09 May 2017
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis Grant US-9365852-B2 United States of America 14 Jun 2016
Methods of making DLL3 antibody drug conjugates Grant US-9358304-B1 United States of America 07 Jun 2016
Kits containing DLL3 antibody drug conjugates Grant US-9352051-B1 United States of America 31 May 2016
Methods of delivering DLL3 antibody drug conjugates Grant US-9345784-B1 United States of America 24 May 2016
Anti-DLL3 antibody drug conjugates and methods of use Grant US-9155803-B1 United States of America 13 Oct 2015
Anti-DLL3 antibody drug conjugates and methods of use Grant US-9133271-B1 United States of America 15 Sep 2015
Anti-DLL3 antibody drug conjugates for treating cancer Grant US-9107961-B2 United States of America 18 Aug 2015
Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies Grant US-9090683-B2 United States of America 28 Jul 2015
Anti-DLL3 antibody drug conjugates and methods of use Grant US-9089616-B2 United States of America 28 Jul 2015
MicroRNAs differentially expressed in cervical cancer and uses thereof Grant US-9080215-B2 United States of America 14 Jul 2015
Methods and compositions involving miRNA and miRNA inhibitor molecules Grant US-8946177-B2 United States of America 03 Feb 2015
Methods and compositions involving miRNA and miRNA inhibitor molecules Grant US-8765709-B2 United States of America 01 Jul 2014
Micrornas differentially expressed in cervical cancer and uses thereof Grant US-8361714-B2 United States of America 29 Jan 2013
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis Grant US-8258111-B2 United States of America 04 Sep 2012
Methods and compositions involving miRNA and miRNA inhibitor molecules Grant US-8173611-B2 United States of America 08 May 2012
MiR-124 regulated genes and pathways as targets for therapeutic intervention Grant US-8071562-B2 United States of America 06 Dec 2011
Methods and compositions involving miRNA and miRNA inhibitor molecules Grant US-8058250-B2 United States of America 15 Nov 2011
Methods and compositions involving miRNA and miRNA inhibitor molecules Grant US-7960359-B2 United States of America 14 Jun 2011